Mednet Logo

How do you manage adjuvant endocrine therapy for pre-menopausal women with locally advanced, weakly positive ER/PR, HER2 negative breast cancer?

Would a pCR to neoadjuvant chemotherapy change your management? (ER <5%, PR <5%)
Community PollStarted

Which regimen do you use for pre-menopausal women with locally advanced, weakly positive ER/PR, HER2 negative breast cancer?

46 physicians have voted

Join Mednetto vote and see how they answered.

1 Answer
Mednet Member
Mednet Member
Medical Oncology · Northwestern Medicine Cancer Center at KishHealth
Answered on

Likely very little benefit. Reasonable to try tamoxifen if tolerated.

Join for free or sign in to see the full answer